National Research (NASDAQ:NRC) Shares Down 0.5%

National Research Co. (NASDAQ:NRC) fell 0.5% on Thursday . The company traded as low as $63.99 and last traded at $64.18, 547 shares traded hands during trading. A decline of 99% from the average session volume of 45,722 shares. The stock had previously closed at $64.51.

The stock has a 50-day simple moving average of $32.61 and a two-hundred day simple moving average of $30.43. The company has a quick ratio of 0.58, a current ratio of 0.58 and a debt-to-equity ratio of 1.46. The firm has a market cap of $1.57 billion, a PE ratio of 61.71 and a beta of 0.80.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Nuveen Asset Management LLC acquired a new stake in shares of National Research in the second quarter valued at about $2,920,000. Citadel Advisors LLC boosted its holdings in shares of National Research by 123.9% in the 2nd quarter. Citadel Advisors LLC now owns 14,718 shares of the company’s stock valued at $848,000 after buying an additional 8,144 shares in the last quarter. D. E. Shaw & Co. Inc. acquired a new position in shares of National Research in the 2nd quarter valued at $228,000. Bank of America Corp DE boosted its holdings in shares of National Research by 21.3% in the 2nd quarter. Bank of America Corp DE now owns 11,648 shares of the company’s stock valued at $670,000 after buying an additional 2,045 shares in the last quarter. Finally, Invesco Ltd. boosted its holdings in shares of National Research by 43.2% in the 2nd quarter. Invesco Ltd. now owns 15,278 shares of the company’s stock valued at $880,000 after buying an additional 4,607 shares in the last quarter. Institutional investors and hedge funds own 35.50% of the company’s stock.

National Research Company Profile (NASDAQ:NRC)

National Research Corporation (NRC) is a provider of analytics and insights that facilitate revenue growth, patient, employee and customer retention and patient engagement for healthcare providers, payers and other healthcare organizations. The Company’s portfolio of subscription-based solutions provides information and analysis to healthcare organizations and payers across a range of mission-critical, constituent-related elements, including patient experience and satisfaction, community population health risks, workforce engagement, community perceptions, and physician engagement.

Further Reading: How analysts view the yield curve

Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.